Evelo Biosciences Stock Price

-0.31 (-10.3%)
Upgrade to Real-Time
Regular Market
Volume 56,422
Bid Price 2.70
Ask Price 2.73
News -
Day High 3.0089


52 Week Range


Day Low 2.70
Company Name Stock Ticker Symbol Market Type
Evelo Biosciences Inc EVLO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.31 -10.3% 2.70 15:41:37
Open Price Low Price High Price Close Price Prev Close
2.95 2.70 3.0089 3.01
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,210 56,422 $ 2.77 $ 156,194 - 1.4188 - 12.74
Last Trade Time Type Quantity Stock Price Currency
15:41:37 10 $ 2.71 USD


Draw Mode:

Evelo Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 291.35M 107.91M 76.52M $ - $ - -2.31 -1.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 27.96M 0.70%

more financials information »

Evelo Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EVLO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.,1170.6229.81%
1 Month2.343.041.932.2993,7170.3615.38%
3 Months1.623.041.41882.10297,8571.0866.67%
6 Months4.114.361.41882.68319,695-1.41-34.31%
1 Year10.2012.741.41885.12305,790-7.50-73.53%
3 Years5.8619.92831.41887.23209,596-3.16-53.92%
5 Years16.0019.92831.41887.74166,745-13.30-83.13%

Evelo Biosciences Description

Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. Its lead product candidate under development is EDP1815, which is for the treatment of inflammatory diseases and the hyperinflammatory response associated with COVID-19. Other products in the pipeline include EDP1867 and EDP2939 for the treatment of inflammatory disease and EDP1908 for the treatment of cancer.

Your Recent History
Evelo Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now